Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration

Indigenous Peoples have cultivated and protected natural psychoactive medicines through ceremony, kinship, and spiritual responsibility across generations, yet their long-standing contributions have often been marginalized through extractive research, commercialization, and policy exclusion. It is Indigenous communities that have stewarded and gained expertise working with psychoactive medicines for centuries, yet they remain underrepresented within the scientific discourse. This commentary advances the case for reciprocal and equitable collaboration in psychedelic science, grounded in Indigenous sovereignty, cultural and intellectual property rights, and governance. Drawing on traditions involving ayahuasca, psilocybin, peyote, and iboga, we illustrate how Indigenous methodologies, including ritual, community-based practices, and ecological approaches, offer insights critical to both safety and efficacy. We argue that research and policy must embed free, prior, and informed consent, equitable benefit-sharing, and Indigenous leadership. Such efforts require moving past tokenistic inclusion toward meaningful collaboration and systemic change in psychedelic research that is both scientifically rigorous and culturally just. We conclude by calling for more formal, transparent, and globally legitimate convening processes, such as those modeled on WHO global consultations, that can bring Indigenous leaders, researchers, and policymakers together in dialogue. These steps represent profound acts of inclusion essential for these medicines to realize their full potential to heal and transform.

Authors

Institutions

Publication Details

Journal
Journal of Psychopharmacology
Published
2026-01-30
DOI
https://doi.org/10.1177/02698811251387104
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration

Brian Rush, Jack E. Henningfield, Pamela Kryskow, Sandor Iron Rope et al.
Journal of Psychopharmacology
Psychedelics and Drug Studies
article

Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration

Brian Rush, Jack E. Henningfield, Pamela Kryskow, Sandor Iron Rope, Heather Kuiper, Marlena Robbins, Charlie Grob, Magar, Brian Anderson, Óscar Martín López Fernández (Lobo Blanco), Anja Loizaga-Velder, Ismail Lourido Ali, Miriam Volat
article en

Abstract

Indigenous Peoples have cultivated and protected natural psychoactive medicines through ceremony, kinship, and spiritual responsibility across generations, yet their long-standing contributions have often been marginalized through extractive research, commercialization, and policy exclusion. It is Indigenous communities that have stewarded and gained expertise working with psychoactive medicines for centuries, yet they remain underrepresented within the scientific discourse. This commentary advances the case for reciprocal and equitable collaboration in psychedelic science, grounded in Indigenous sovereignty, cultural and intellectual property rights, and governance. Drawing on traditions involving ayahuasca, psilocybin, peyote, and iboga, we illustrate how Indigenous methodologies, including ritual, community-based practices, and ecological approaches, offer insights critical to both safety and efficacy. We argue that research and policy must embed free, prior, and informed consent, equitable benefit-sharing, and Indigenous leadership. Such efforts require moving past tokenistic inclusion toward meaningful collaboration and systemic change in psychedelic research that is both scientifically rigorous and culturally just. We conclude by calling for more formal, transparent, and globally legitimate convening processes, such as those modeled on WHO global consultations, that can bring Indigenous leaders, researchers, and policymakers together in dialogue. These steps represent profound acts of inclusion essential for these medicines to realize their full potential to heal and transform.

Journal of Psychopharmacology
The Conservation Fund (US), Centre for Addiction and Mental Health (CA), Johns Hopkins University (US), University of California, Los Angeles (US), University of California, San Francisco (US), Johns Hopkins Medicine (US), UCLA Medical Center (US), Vancouver Island University (CA), Advisory Board Company (United States) (US), Taoka Hospital (JP), Universidad Interglobal (MX), World Health Organization (CH), Multidisciplinary Association for Psychedelic Studies (US), Berkeley Public Health Division (US), Abt Global (United States) (US), Harbor–UCLA Medical Center (US), University of California, Berkeley (US)
Reduced inequalities
Openalex Percentile: Top 74%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.